Literature DB >> 24390493

Thermotropic phase behavior of hydrogenated soybean phosphatidylcholine-cholesterol binary liposome membrane.

Hiroki Kitayama1, Yuki Takechi, Nobutake Tamai, Hitoshi Matsuki, Chikako Yomota, Hiroyuki Saito.   

Abstract

By combination of differential scanning calorimetry (DSC) and fluorescence spectroscopy of 6-propionyl-2-(dimethylamino)naphthalene (Prodan), we elucidated the thermotropic phase behavior of hydrogenated soybean phosphatidylcholine (HSPC)-cholesterol binary liposome membrane which has similar lipid composition to Doxil®, the widely used liposome product in treatment of various tumors. We found that the characteristic points at cholesterol mole fraction (Xch)=0.023 and 0.077 correspond to the hexagonal lattice, in which cholesterol molecules are considered to be regularly distributed in all regions of HSPC lipid bilayer with 1 : 42 and 1 : 12 units, respectively, as static averaged structures. Apparent endothermic peak disappeared at Xch=0.40 in the DSC thermograms, indicating the existence of single liquid ordered phase at Xch>0.40. In addition, fluorescence measurements of Prodan and its lauroyl derivative in poly(ethylene glycol) (PEG)-modified liposomes indicated that PEG modification has a negligible effect on the phase behavior of HSPC-cholesterol binary liposome membrane. These results may provide useful information in developing novel liposome products whose stability and encapsulated drug release are controlled.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390493     DOI: 10.1248/cpb.c13-00587

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  5 in total

1.  Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes.

Authors:  Seham A Elkheshen; Rania M Hathout; Engy A Abdel Azim; Marwa A Fouly; Nada M El Hoffy
Journal:  Int J Nanomedicine       Date:  2022-06-25

Review 2.  Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging.

Authors:  Silvia Franzé; Francesca Selmin; Elena Samaritani; Paola Minghetti; Francesco Cilurzo
Journal:  Pharmaceutics       Date:  2018-08-28       Impact factor: 6.321

3.  Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation.

Authors:  Rickard Nordström; Lin Zhu; Johan Härmark; Yael Levi-Kalisman; Erez Koren; Yechezkel Barenholz; Genia Levinton; Dima Shamrakov
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

4.  Preparation of a PEGylated liposome that co-encapsulates l-arginine and doxorubicin to achieve a synergistic anticancer effect.

Authors:  Haitao Feng; Jeong-Hun Kang; Song Qi; Akihiro Kishimura; Takeshi Mori; Yoshiki Katayama
Journal:  RSC Adv       Date:  2021-10-21       Impact factor: 3.361

5.  Can Pulsed Electromagnetic Fields Trigger On-Demand Drug Release from High-Tm Magnetoliposomes?

Authors:  Martina Nardoni; Elena Della Valle; Micaela Liberti; Michela Relucenti; Maria Antonietta Casadei; Patrizia Paolicelli; Francesca Apollonio; Stefania Petralito
Journal:  Nanomaterials (Basel)       Date:  2018-03-27       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.